ArticleJournal of immunology (Baltimore, Md. : 1950)2022

Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells.

Nazanin Kiapour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.